Valiant Organics Limited — Important, 13-11-2024: Financial Result Updates

Valiant Organics reported its consolidated financial results for the quarter ending September 30, 2024. The total revenue from operations stood at ₹16,017.58 crore, reflecting a decline compared to the previous quarter's revenue of ₹16,791.70 crore and ₹20,309.83 crore for the same quarter last year. The decrease in revenue can be attributed to low demand across product lines, resulting in reduced sales volume and downward price corrections.

The company recorded a net loss of ₹1,246.88 crore for the quarter, compared to a profit of ₹474.84 crore in the previous year. The loss was driven by operational challenges, including under-utilized capacity across facilities. Earnings Per Share (EPS) was reported at (₹4.52) as compared to ₹1.58 from the previous year.

Operational costs totaled ₹17,485.29 crore, a rise from ₹16,589.39 crore in the previous quarter, primarily due to increased cost of materials consumed and higher finance costs. The company’s finance costs were notably high at ₹1,315.43 crore.

On the balance sheet, total assets decreased to ₹1,17,344.39 crore from ₹1,24,796.48 crore at the end of the previous financial year, indicating potential liquidity concerns. The current ratio reflects pressures, with current liabilities increasing to ₹35,993.13 crore against current assets of ₹34,286.59 crore.

Investor sentiment towards Valiant Organics remains cautious due to ongoing operational challenges and financial pressures, suggesting a hold strategy as the company navigates a recovery period.